Product/Composition:- | Mebendazole tablet |
---|---|
Strength:- | 100 mg |
Form:- | Tablets |
Reference Brands:- | Vermox(US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Mebendazole tablets inhibit microtubule formation in parasitic worms, disrupting nutrient absorption and leading to their death. It effectively treats intestinal worms such as roundworms, hookworms, and whipworms. Benefits include rapid symptom relief, reduced infection transmission, and effective eradication of parasitic infestations supporting gastrointestinal health.
Mebendazole tablets, marketed as Vermox, are approved in the US by the FDA and in the EU via EMA for treating intestinal parasitic infections. Regulatory approval requires dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for approval, while the EMA ensures compliance with regional safety and manufacturing standards. For dossier preparation, regulatory pathways, and market access guidance, visit PharmaTradz. Proper adherence supports timely approval, safe medication use, and global availability, enabling effective treatment of parasitic infections worldwide.